B
Bailink Pharmaceutical Technology (Shanghai)
A loyal partner providing advanced bioprocessing solutions for the rapid development of biotechnology industries
About Bailink Pharmaceutical Technology (Shanghai)
BioLink is a Shanghai-based company at the forefront of bioprocessing technology, catering to the needs of biopharmaceutical companies and research institutions. The company specializes in providing cutting-edge products and solutions that accelerate the development of biotechnology industries, particularly in the areas of antibodies, vaccines, recombinant proteins, and advanced therapies. BioLink's core offerings include single-use bioprocessing and chromatography products, manufactured in their state-of-the-art facilities across China. These products ensure continuous and stable production for their clients, adhering to stringent quality standards as evidenced by over 1000 verification documents, including ISO 9001:2015 certification. The company's strength lies in its robust engineering team, capable of meeting diverse customization needs and providing comprehensive process support. BioLink's commitment to excellence extends to their after-sales service, offering professional support and quick response times to maximize their clients' business value. By focusing on innovation and reliability, BioLink plays a crucial role in advancing the biotechnology sector and contributing to the development of life-saving therapies and treatments.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Nov 2024 | $28M | $110M | Spinnotec · Alwin Capital · Zoo Capital · Cathay Capital | ↗ |
| SERIES A✓Equity / VC | Feb 2024 | — | — | Sino Biological · Spinnotec · Xincheng Fund · Yuanxi Haihe Fund | ↗ |
Growth signals
Latest recorded traffic for Bailink Pharmaceutical Technology (Shanghai) is 1.5K monthly website visits, up 114.3% over the last three months. Bailink Pharmaceutical Technology (Shanghai)'s team grew 128% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Bailink Pharmaceutical Technology (Shanghai) in the Huangpu ecosystem
The Bailink Pharmaceutical Technology (Shanghai) office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A13 investors entered at this stage
Qiming Venture Partners
Sino Biological
Spinnotec- XFXincheng Fund
- YFYuanxi Haihe Fund
- AFAalex Industrial Fund
Cathay Capital- BCBridge Hill Capital
- BFBloomage Healthcare Consumer Goods Industry Fund
Alwin Capital
Zoo Capital
Shenzhen Capital Group
Asymchem
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bailink Pharmaceutical Technology (Shanghai) on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bailink Pharmaceutical Technology (Shanghai)’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








